Table 2. Patient's Characteristics Between Mayo-0 and Mayo-1 Group.
| Variable | Mayo-0 n=43 |
Mayo-1 n=45 |
P-value |
|---|---|---|---|
| Gender (M/F) | 23/20 | 22/23 | 0.666 |
| Age at diagnosis (yr), median (range) | 34 (15–75) | 34 (10–71) | 0.333 |
| Extent of disease | 0.361 | ||
| Extensive colitis | 17 (39.5) | 15 (33.3) | |
| Left-sided | 6 (14.0) | 15 (33.3) | |
| Proctitis | 19 (44.2) | 15 (33.3) | |
| Unclear | 1 (2.3) | 0 (0) | |
| Maintenance therapy | |||
| 5-ASA | 35 (81.4) | 37 (82.2) | 0.860 |
| AZA/6MP | 5 (11.6) | 7 (15.6) | 0.821 |
| GMAA | 0 (0) | 1 (2.2) | N/A |
| TNF-α antagonists | 1 (2.3) | 5 (11.1) | N/A |
| None | 5 (11.6) | 3 (6.7) | N/A |
| History of treatment with corticosteroid | 9 (20.9) | 14 (31.1) | 0.399 |
| Corticosteroid refractory | 2 (4.7) | 2 (4.4) | N/A |
| Corticosteroid dependent | 2 (4.7) | 4 (8.9) | N/A |
Values are presented as n (%).
Categorical and continuous data were compared using a two-tailed Fisher exact test, Chi-squared test and Mann-Whitney U test.
M, male; F, female; 5-ASA, 5-aminosalicylic acid; AZA/6MP, Azathioprine/6-mercaptopurine; GMAA, granulocyte monocyte adsorption apheresis; TNF, tumor necrosis factor; N/A, not applicable.